NCT03788148View on ClinicalTrials.gov

Bare Metal Stents and Drug Eluting Stents in Patients Who Underwent Blood Transfusion

CompletedOBSERVATIONAL
Enrollment

28,322

Participants

Timeline

Start Date

January 3, 2018

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Erythrocyte TransfusionPercutaneous Coronary InterventionRevascularization
Interventions
DEVICE

Stent, red blood cell transfusion

BMS (Bare Metal Stent) and DES (drug-eluting stent) transplants with periprocedural red blood cell transfusion

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT03788148 - Bare Metal Stents and Drug Eluting Stents in Patients Who Underwent Blood Transfusion | Biotech Hunter | Biotech Hunter